Medikodas - Company finances
|
EUR
|
2022
From: 2022-12-20
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 5,600 | 75,349 | 218,973 |
| Profit before tax | 0 | -2,854 | -73,923 | -3,815 |
| Net profit | 0 | -2,854 | -73,923 | -3,815 |
| Equity | 2,500 | 29,646 | -44,277 | -48,091 |
| Liabilities | 0 | 204 | 212,654 | 202,962 |
| Non-current assets | 0 | 0 | 138,650 | 113,651 |
| Current assets | 2,500 | 29,850 | 29,727 | 41,220 |
| Total assets | 2,500 | 29,850 | 168,377 | 154,871 |
|
Taxes paid
|
||||
| STI taxes | - | 232 | 6,339 | 28,573 |
| Social insurance contributions | - | - | 11,740 | 23,309 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +1245.5% | +190.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -9.6% | -43.9% | -2.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -9.6% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -51.0% | -98.1% | -1.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -51.0% | -98.1% | -1.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 5,600 | 17,388 | 27,372 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medikodas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-27 | 2026-08-31 | 281.95 |
| 2026-08-26 | 2026-08-26 | 35.83 |
| 2026-08-23 | 2026-08-23 | 35.83 |
| 2026-08-19 | 2026-08-19 | 35.83 |
| 2026-07-24 | 2026-07-26 | 289.90 |
| 2026-07-23 | 2026-07-23 | 1827.11 |
| 2026-07-19 | 2026-07-22 | 1820.54 |
| 2026-07-16 | 2026-07-17 | 1820.54 |
| 2026-06-18 | 2026-06-21 | 1576.17 |
| 2026-05-17 | 2026-05-17 | 1335.26 |
| 2026-03-27 | 2026-03-27 | 1943.39 |
| 2026-03-17 | 2026-03-22 | 1943.39 |
| 2026-02-18 | 2026-02-19 | 2002.66 |
| 2025-10-16 | 2025-10-19 | 1855.61 |
| 2025-07-24 | 2025-08-07 | 1.79 |
| 2025-07-16 | 2025-07-16 | 2417.69 |
| 2025-06-17 | 2025-06-19 | 1944.87 |
| 2025-05-04 | 2025-05-14 | 0.50 |
| 2025-04-30 | 2025-04-30 | 0.04 |
| 2025-04-24 | 2025-04-29 | 0.50 |
| 2025-04-16 | 2025-04-23 | 0.04 |
| 2023-08-17 | 2023-08-20 | 0.04 |
| 2023-07-28 | 2023-08-09 | 0.04 |
| 2023-07-24 | 2023-07-25 | 0.04 |
| 2023-06-16 | 2023-06-19 | 27.44 |
Medikodas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-02 | 2026-07-26 | 1.5 |
| 2026-06-28 | 2026-07-01 | 1115.0 |
| 2026-06-03 | 2026-06-05 | 1.08 |
| 2026-06-01 | 2026-06-02 | 676.95 |
| 2026-05-28 | 2026-05-31 | 675.87 |
| 2025-07-22 | 2025-07-23 | 4.01 |
| 2025-07-16 | 2025-07-21 | 425.46 |
| 2025-07-01 | 2025-07-15 | 4.01 |
| 2025-06-29 | 2025-06-30 | 3.17 |
| 2025-06-28 | 2025-06-28 | 1551.17 |
| 2025-06-15 | 2025-06-27 | 2.75 |
| 2025-06-14 | 2025-06-14 | 2.81 |
| 2025-06-12 | 2025-06-13 | 5.42 |
| 2025-06-11 | 2025-06-11 | 2.81 |
| 2025-06-04 | 2025-06-10 | 2.67 |
| 2025-06-02 | 2025-06-03 | 261.72 |
| 2025-05-31 | 2025-06-01 | 259.05 |
| 2025-05-29 | 2025-05-30 | 2390.94 |
| 2025-05-17 | 2025-05-28 | 0.94 |
| 2025-05-03 | 2025-05-16 | 2.35 |
| 2025-05-01 | 2025-05-02 | 1727.35 |
| 2025-04-28 | 2025-04-30 | 1725.0 |
| 2025-04-02 | 2025-04-14 | 0.78 |
| 2025-03-02 | 2025-03-27 | 0.3 |
| 2025-02-02 | 2025-02-26 | 0.92 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medikodas, UAB (code 306199804) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated €219.0K in revenue, up from €75.3K in 2024 and €5.6K in 2023, indicating a strong expansion in turnover over the last two years. Revenue growth was 190.6% year on year in 2025 and 3,810.2% over two years. Despite this growth, profitability remained weak: net profit was a loss of €3.8K in 2025, compared with a loss of €73.9K in 2024 and €2.9K in 2023. The 2025 profit margin was -1.7%, a marked improvement from -98.1% in 2024. At year-end 2025, total assets stood at €154.9K, equity at -€48.1K, and liabilities at €203.0K. Long-term assets were €113.7K and short-term assets €41.2K. Asset turnover was 1.41x, ROA was -2.5%, and revenue per employee reached €27.4K.